X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1625) 1625
diuretics (1044) 1044
science & technology (898) 898
life sciences & biomedicine (886) 886
sodium chloride symporter inhibitors - adverse effects (808) 808
female (780) 780
male (763) 763
benzothiadiazines (755) 755
hypertension - drug therapy (707) 707
sodium chloride symporter inhibitors - therapeutic use (650) 650
aged (597) 597
middle aged (576) 576
adult (331) 331
cardiovascular system & cardiology (305) 305
drug therapy, combination (288) 288
antihypertensive agents - therapeutic use (273) 273
hypertension (255) 255
antihypertensive agents - adverse effects (254) 254
risk factors (234) 234
treatment outcome (221) 221
sodium chloride symporter inhibitors - administration & dosage (214) 214
blood pressure - drug effects (202) 202
general & internal medicine (198) 198
aged, 80 and over (193) 193
heart failure - drug therapy (185) 185
medicine, general & internal (184) 184
sodium potassium chloride symporter inhibitors - therapeutic use (180) 180
cardiac & cardiovascular systems (178) 178
diuretics - adverse effects (170) 170
animals (167) 167
adrenergic beta-antagonists - therapeutic use (156) 156
diuretics - therapeutic use (155) 155
hypokalemia - chemically induced (152) 152
sodium potassium chloride symporter inhibitors - adverse effects (150) 150
heart failure (147) 147
hypertension - physiopathology (147) 147
angiotensin-converting enzyme inhibitors - therapeutic use (143) 143
pharmacology & pharmacy (138) 138
time factors (136) 136
peripheral vascular disease (133) 133
hydrochlorothiazide - therapeutic use (123) 123
drug therapy (118) 118
hypertension - complications (117) 117
hydrochlorothiazide - adverse effects (115) 115
sodium potassium chloride symporter inhibitors - administration & dosage (107) 107
sodium chloride symporter inhibitors - pharmacology (106) 106
adrenergic beta-antagonists - adverse effects (105) 105
calcium channel blockers - therapeutic use (103) 103
dose-response relationship, drug (102) 102
double-blind method (101) 101
antihypertensive agents - administration & dosage (93) 93
hyponatremia - chemically induced (92) 92
urology & nephrology (90) 90
clinical trials as topic (86) 86
prospective studies (86) 86
thiazides (86) 86
heart failure - physiopathology (85) 85
angiotensin-converting enzyme inhibitors - adverse effects (82) 82
blood pressure (82) 82
furosemide - adverse effects (81) 81
potassium - blood (80) 80
retrospective studies (79) 79
medicine & public health (78) 78
follow-up studies (77) 77
randomized controlled trials as topic (76) 76
hydrochlorothiazide - administration & dosage (75) 75
mortality (74) 74
abridged index medicus (71) 71
furosemide - therapeutic use (71) 71
hypertension - blood (70) 70
furosemide (69) 69
drug combinations (67) 67
drug interactions (67) 67
analysis (66) 66
hydrochlorothiazide (65) 65
care and treatment (64) 64
diuretics - pharmacology (64) 64
health aspects (64) 64
research (64) 64
age factors (63) 63
rats (63) 63
adolescent (62) 62
acute disease (58) 58
dosage and administration (58) 58
prognosis (56) 56
risk (56) 56
sodium (56) 56
furosemide - administration & dosage (55) 55
calcium channel blockers - adverse effects (53) 53
heart failure - mortality (52) 52
potassium - metabolism (52) 52
antihypertensive agents - pharmacology (51) 51
research article (51) 51
angiotensin-converting enzyme inhibitors - administration & dosage (49) 49
diuretics - administration & dosage (49) 49
kidney - drug effects (49) 49
internal medicine (48) 48
potassium (48) 48
risk assessment (46) 46
sodium - metabolism (46) 46
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1527) 1527
German (46) 46
Japanese (41) 41
French (32) 32
Russian (19) 19
Norwegian (17) 17
Italian (14) 14
Danish (11) 11
Spanish (9) 9
Polish (7) 7
Swedish (6) 6
Hungarian (5) 5
Dutch (4) 4
Chinese (3) 3
Czech (2) 2
Finnish (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert review of cardiovascular therapy, ISSN 1477-9072, 06/2010, Volume 8, Issue 6, pp. 793 - 802
Journal Article
Lancet neurology, ISSN 1474-4422, 05/2015, Volume 14, Issue 5, pp. 469 - 477
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 364, Issue 9, pp. 797 - 805
Journal Article
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 276 - 284
Thiazide diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers all cause reactive rises in plasma renin activity... 
Hypertension | Aliskiren | Renin inhibitor | Renin-angiotensin-aldosterone system | Combination therapy | Plasma renin activity | Ambulatory blood pressure measurement | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Amides | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Biphenyl Compounds - therapeutic use | Hypertension - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Drug Therapy, Combination | Hypertension - diagnosis | Ramipril - adverse effects | Hydrochlorothiazide - adverse effects | Fumarates - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Fumarates - blood | Renin - antagonists & inhibitors | Tetrazoles - therapeutic use | Aged | Patient Compliance | Tetrazoles - adverse effects | Blood Pressure Monitoring, Ambulatory | Hydrochlorothiazide - therapeutic use
Journal Article
Journal Article
Cochrane library, ISSN 1465-1858, 05/2015, Volume 2015, Issue 5, p. CD003825
Journal Article
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | Life Sciences & Biomedicine | Science & Technology | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
Journal of the American Society of Hypertension, ISSN 1933-1711, 09/2012, Volume 6, Issue 5, pp. 299 - 308
Journal Article